Allergic responses reduce the relaxant effect of β-agonists but not potassium channel openers in guinea-pig isolated trachea

European Respiratory Journal

Volumn 9, Issue 10, 1996, Pages 2050-2056

  Houjou, S ^a,b   Iizuka, K ^a   Dobashi, K ^a   Nakazawa, T ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

adenosine trisphosphate sensitive potassium channel; beta adrenergic hyporesponsiveness; bronchial asthma; isoprenaline; theophylline

Indexed keywords

4 (N ACETYL N HYDROXYAMINO) 6 CYANO 3,4 DIHYDRO 2,2 DIMETHYL 2H 1 BENZOPYRAN 3 OL; 4 (N!ACETYL N HYDROXYAMINO) 6 CYANO 3,4 DIHYDRO 2,2 DIMETHYL 2H 1 BENZOPYRAN 3 OL; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; OVALBUMIN; POTASSIUM CHANNEL STIMULATING AGENT; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CROSS TOLERANCE; GUINEA PIG; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; TACHYPHYLAXIS; TRACHEA;

EID: 0029784799     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09102050     Document Type: Article

References (34)

1. Vandenburg MJ, Woodward SR, Hossain M, Stewart-Long P, Tasker TCG. Potassium channel activators lower blood pressure: an initial study of BRL34915 in hypertensive patients. J Hypertension 1986; 4: S166-167.
2. Vandenburg MJ, Woodward SR, Stewart-Long P, et al. Potassium channel activators: antihypertensive activity and adverse effect profile of BRL34915. J Hypertension 1987; 5: S193-S195.
3. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 1988; 9: 21-28.
4. + channels. Trends Pharmacol Sci 1995; 16: 1-4.
5. Small RC, Berry JL, Foster RW, Green KA, Murray MA. The pharmacology of potassium channel modulators in airway smooth muscle: relevance to airway disease. In: Weston AH, Hamilton TC, eds. Frontiers in Pharmacology and Therapeutics. Potassium Channel Modulators: Pharmacological, Molecular and Clinical Aspects. London. Blackwell Scientific Publications, 1993; pp. 422-461.
6. Longmore J, Weston AH. Effects of cromakalim and glibenclamide on isolated strips of bovine tracheal smooth muscle. Br J Pharmacol 1989; 98: 888.
7. Longmore J, Weston AH, Tresize D. The effects of cromakalim and diazoxide on potassium and rubidium permeability in bovine trachal smooth muscle. Br J Pharmacol 1990; 183: 675.
8. Longmore J, Bray KM, Weston AH. The contribution of Rb-permeable potassium channels to the relaxant and membrane hyperpolarizing actions of cromakalim, RP49356, and diazoxide in bovine tracheal smooth muscle. Br J Pharmacol 1991; 102: 979-985.
9. Arch JRS, Buckle DR, Bumstead J, Clarke CD, Taylor JF, Taylor SG. Evaluation of the potassium channel activator cromakalim (BRL34915) as a bronchodilator in the guinea-pig: comparison with nifedipine. Br J Pharmacol 1988; 95: 763-770.
10. 2+ release in canine coronary artery. Naunyn Sch Arch Pharmacol 1992; 346: 691-700.
11. 2+ of contractile elements in canine coronary artery. Naunyn Sch Arch Pharmacol 1993; 347: 438-444.
12. Allen SL, Boyle JP, Cortijo J, Foster RW, Morgan GP, Small RC. Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol 1986; 89: 395-405.
13. Berry JL, Elliott KRF, Foster RW, Green KA, Murray MA, Small RC. Mechanical, biochemical and electrophysiological studies of RP 49356 and cromakalim in guinea-pig and bovine trachealis muscle. Pulm Pharmacol 1991; 4: 91-98.
14. Murray MA, Boyle JP, Small RC. Cromakalim-induced relaxation of guinea-pig trachealis: antagonism by glibenclamide and phentolamine. Br J Pharmacol 1989; 98: 865-874.
15. Williams AJ, Lee TE, Cochrane CM, et al. Attenuation of nocturnal asthma by cromakalim. Lancet 1990; 336: 334-336.
16. Black JL, Armour CL, Johnson PR, Alouan LA, Barnes PJ. The action of a potassium channel activator, BRL38227 (lemakalim), on human airway smooth muscle. Am Rev Respir Dis 1990; 142: 1384-1389.
17. Miura M, Belvisi MG, Stretton CD, Yacoub MH, Barnes PJ. Role of potassium channels in bronchodilator responses in human airway. Am Rev Respir Dis 1992; 146: 132-136.
18. Barnes PJ, Dollery CT, MacDermot J. Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma. Nature 1980; 285: 569-571.
19. Brooks SM, McGowan K, Bernstein IL, Alternau P, Peagler J. Relationship between number of beta-adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol 1979; 63: 401-406.
20. Conolly ME, Greenmacre JK. The lymphocyte β-adrenoceptor in normal subjects and patients with bronchial asthma. J Clin Invest 1976; 58: 1307-1316.
21. Kalisker A, Nelson HE, Middleton EJ. Drug-induced changes of adenylate cyclase activity in cells from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol 1977; 60: 259-265.
22. Iizuka K, Yoshie Y, Nakazawa T. Hormone-sensitive adenylate cyclase in lymphocytes from asthmatic patients: possible defect at the postreceptor sites. Ann Allergy 1991; 66: 167-172.
23. Yukawa T, Makino S, Fukuda T, Kamikawa Y. Experimental model of anaphylaxis-induced beta-adrenergic blockade in the airways. Ann Allergy 1986; 57: 219-224.
24. + channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state. J Pharmacol Exp Ther 1992; 261: 730-736.
25. 2+ mobilization in smooth muscle of rabbit mesenteric artery. Br J Pharmacol 1994; 111: 165-172.
26. Taylor SG, Bumstead J, Morris JEJ, Shaw DJ, Taylor IF. Cromakalim inhibits cholinergic-mediated responses in human isolated bronchioles but not in guinea-pig airways. Br J Pharmacol 1988; 95: 795P.
27. Paciorek PM, Cowlrick IS, Perkins RS, Taylor JC, Wilkinson GF, Waterfall JF. Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig. Br J Pharmacol 1990; 100: 289-294.
28. Englert HC, Wirth K, Gehring D, et al. Airway pharmacology of the potassium channel opener, HOE 234, in guinea-pigs: in vitro and in vivo studies. Eur J Pharmacol 1992; 210: 69-75.
29. + channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim. Br J Pharmacol 1994; 113: 889-897.
30. Kidney JC, Worsdell YM, Lavender EA, Chung KF, Barnes PI. The effect of an ATP-dependent potassium channel activator, BRL38227, in asthmatics. Am Rev Respir Dis 1991; 143: A423.
31. Kidney JC, Fuller RW, Worsdell YM, Lavender EA, Chung KF, Barnes PJ. Effect of an oral potassium channel activator, BRL38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol. Thorax 1993; 48: 130-133.
32. Black JL, Barnes PJ. Potassium channels and airway function: new therapeutic prospects. Thorax 1990; 45: 213-218.
33. Villanove X, Marthan R, De Lara MA, et al. Sensitization decreases relaxation in human isolated airways. Am Rev Respir Dis 1993; 148: 107-112.
34. Downing SJ, Hollingsworth M. One-way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo. Br J Pharmacol 1992; 105: 129-134.